The ex-pharma exec leading Trump's COVID-19 vaccine program has $10 million in stock options for a company getting federal funding
Published
The former pharma executive tapped by President Donald Trump to lead the federal government's hunt for a COVID-19 vaccine has more than $10 million in stock options in one of the companies receiving federal funding. Dr Moncef Slaoui, a Belgian-American, was this week named Chief Scientist for Trump's "Operation Warp Speed,"...
Full Article